PapersFlow Research Brief
Cancer Risks and Factors
Research Guide
What is Cancer Risks and Factors?
Cancer risks and factors refer to modifiable and non-modifiable elements, including obesity, body mass index, adiposity, hormonal influences, and metabolic syndrome, that influence the incidence, prognosis, and treatment outcomes of various cancers such as breast cancer.
This field encompasses 51,461 papers examining relationships between obesity, adiposity, body mass index, and cancer risks across sites including breast cancer. Calle et al. (2003) in "Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults" found increased body weight associated with higher death rates for all cancers combined and specific sites. Renehan et al. (2008) in "Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies" conducted a meta-analysis linking higher BMI to elevated cancer incidence.
Topic Hierarchy
Research Sub-Topics
Obesity and Breast Cancer Risk
This sub-topic investigates epidemiological links between BMI, adiposity, and postmenopausal breast cancer incidence via cohort studies and meta-analyses. Mechanisms like insulin, estrogen, and inflammation are explored.
Adiposity Impact on Cancer Prognosis
Studies how visceral fat influences recurrence, metastasis, and survival across cancers using imaging and biomarkers. Researchers analyze adjuvant therapy efficacy in obese patients.
Metabolic Syndrome in Cancer Etiology
Examines hyperglycemia, dyslipidemia, and hypertension clusters elevating risks for colorectal, pancreatic, and endometrial cancers. Mendelian randomization tests causality.
Obesity Effects on Cancer Chemotherapy
This area assesses dosing, toxicity, and response variations in obese patients receiving cytotoxics. Pharmacokinetic studies address altered drug distribution in adipose tissue.
Hormonal Mechanisms Linking Adiposity to Cancer
Focuses on adipose-derived leptin, adiponectin, estrogens, and IGF-1 driving mammary and prostate oncogenesis. Lab and population studies dissect signaling pathways.
Why It Matters
Understanding cancer risks and factors guides public health interventions and clinical decisions on prevention and treatment. Calle et al. (2003) demonstrated in a prospective U.S. cohort that overweight and obesity raised death rates from 13 specific cancers, with hazard ratios increasing with BMI levels, informing obesity management strategies. Rossouw (2002) reported in "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women" that combined hormone therapy increased breast cancer risk by 26% over 5.2 years in postmenopausal women, leading to revised guidelines limiting such therapies. Fisher et al. (1998) showed in "Tamoxifen for Prevention of Breast Cancer" that tamoxifen reduced invasive breast cancer incidence by 49% in high-risk women, despite side effects, supporting its use in targeted prevention. These findings impact oncology by linking adiposity and hormones to survival rates and chemotherapy responses in breast cancer patients.
Reading Guide
Where to Start
"Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults" by Calle et al. (2003) provides a clear prospective cohort analysis linking body weight to cancer death rates across sites, serving as an accessible entry to obesity-cancer associations.
Key Papers Explained
Calle et al. (2003) "Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults" establishes obesity's link to cancer mortality in a U.S. cohort. Renehan et al. (2008) "Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies" builds on this with a meta-analysis confirming BMI-incidence relationships globally. Rossouw (2002) "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women" adds hormonal risk data from a randomized trial, while Fisher et al. (1998) "Tamoxifen for Prevention of Breast Cancer" demonstrates mitigation strategies in breast cancer. Siegel et al. (2022) "Cancer statistics, 2022" contextualizes these with current U.S. incidence trends.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent emphasis remains on obesity's role in cancer outcomes as detailed in top-cited works, with no new preprints or news in the last 12 months indicating steady focus on established cohort and meta-analytic evidence.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Cancer statistics, 2022 | 2022 | CA A Cancer Journal fo... | 17.8K | ✓ |
| 2 | Risks and Benefits of Estrogen Plus Progestin in Healthy Postm... | 2002 | JAMA | 15.7K | ✓ |
| 3 | Cancer Statistics, 2009 | 2009 | CA A Cancer Journal fo... | 9.7K | ✓ |
| 4 | Overweight, Obesity, and Mortality from Cancer in a Prospectiv... | 2003 | New England Journal of... | 7.7K | ✓ |
| 5 | Effects of chemotherapy and hormonal therapy for early breast ... | 2005 | The Lancet | 7.6K | ✕ |
| 6 | Tamoxifen for Prevention of Breast Cancer: Report of the Natio... | 1998 | JNCI Journal of the Na... | 5.5K | ✓ |
| 7 | Food, nutrition, physical activity, and the prevention of canc... | 2008 | Choice Reviews Online | 5.4K | ✓ |
| 8 | Cancer incidence and mortality patterns in Europe: Estimates f... | 2013 | European Journal of Ca... | 5.2K | ✓ |
| 9 | Body-mass index and incidence of cancer: a systematic review a... | 2008 | The Lancet | 5.1K | ✕ |
| 10 | Estimates of the cancer incidence and mortality in Europe in 2006 | 2007 | Annals of Oncology | 4.0K | ✓ |
Frequently Asked Questions
What is the link between obesity and cancer mortality?
Calle et al. (2003) in "Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults" analyzed a U.S. cohort and found increased body weight linked to higher death rates for all cancers combined and 13 specific sites. Death rates rose with greater BMI, independent of other factors. This establishes obesity as a significant mortality risk factor.
How does BMI relate to cancer incidence?
Renehan et al. (2008) in "Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies" performed a meta-analysis of prospective studies showing higher BMI associated with increased incidence of multiple cancers. The analysis quantified relative risks per BMI unit increase. Evidence supports BMI as a consistent risk predictor.
What are the effects of estrogen plus progestin on cancer risk?
Rossouw (2002) in "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women" from the Women's Health Initiative trial found combined therapy increased breast cancer risk over 5.2 years. Overall health risks exceeded benefits in healthy postmenopausal women. All-cause mortality remained unaffected.
How effective is tamoxifen in preventing breast cancer?
Fisher et al. (1998) in "Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study" reported tamoxifen reduced invasive breast cancer incidence in high-risk women. The P-1 study confirmed decreases in both invasive and noninvasive cases despite side effects. Its use is appropriate for many at increased risk.
What role does nutrition play in cancer prevention?
Marmot et al. (2008) in "Food, nutrition, physical activity, and the prevention of cancer: a global perspective" explored how food, nutrition, physical activity, and body composition modify cancer risk. Environmental factors like these proved most influential. The report specifies key modifiable factors.
Open Research Questions
- ? To what extent does adiposity independently predict cancer prognosis beyond BMI?
- ? How do metabolic syndrome components interact with obesity to affect breast cancer survival?
- ? What are the precise hormonal pathways linking pregnancy-associated obesity to breast cancer risk?
- ? How does obesity modify chemotherapy efficacy and toxicity in diverse cancer types?
- ? Which cancers show the strongest BMI-mortality associations in recent cohorts?
Recent Trends
The field maintains 51,461 works with no specified 5-year growth rate.
Siegel et al. "Cancer statistics, 2022" updates U.S. incidence through 2018, cited 17,802 times, reflecting ongoing reliance on annual statistics amid stable obesity-cancer research.
2022Research Cancer Risks and Factors with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cancer Risks and Factors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers